• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel.

Studies with isolated membrane fractions have shown that calmodulin (CaM) inhibits the activity of cardiac muscle cell Ca(2+) release channel ryanodine receptor 2 (RyR2). To determine the physiological importance of CaM regulation of RyR2, we generated a mouse with 3 amino acid substitutions (RyR2-W3587A/L3591D/F3603A) in exon 75 of the Ryr2 gene, which encodes the CaM-binding site of RyR2. Homozygous mutant mice showed an increased ratio of heart weight to body weight, greatly reduced fractional shortening of the left ventricle, and lethality at 9-16 days of age. Biochemical analysis of hearts of 7- and 10-day-old homozygous mutant mice indicated an impaired CaM inhibition of RyR2 at micromolar Ca(2+) concentrations, reduction in RyR2 protein levels and sarcoplasmic reticulum Ca(2+) sequestration, and upregulation of genes and/or proteins associated with class II histone deacetylase/myocyte enhancer factor-2 and calcineurin signaling pathways. Sustained Ca(2+) transients, often displaying repeated periods of incomplete Ca(2+) removal, were observed in homozygous cardiomyocytes. Taken together, the data indicate that impaired CaM inhibition of RyR2, associated with defective sarcoplasmic reticulum Ca(2+) release and altered gene expression, leads to cardiac hypertrophy and early death.

Pubmed ID: 17431507

Authors

  • Yamaguchi N
  • Takahashi N
  • Xu L
  • Smithies O
  • Meissner G

Journal

The Journal of clinical investigation

Publication Data

May 3, 2007

Associated Grants

  • Agency: NIAMS NIH HHS, Id: AR 018687
  • Agency: NHLBI NIH HHS, Id: HL 073051
  • Agency: NHLBI NIH HHS, Id: HL 49277
  • Agency: NHLBI NIH HHS, Id: HL 71266
  • Agency: NHLBI NIH HHS, Id: R01 HL049277
  • Agency: NHLBI NIH HHS, Id: R01 HL049277-14
  • Agency: NHLBI NIH HHS, Id: R01 HL049277-15
  • Agency: NHLBI NIH HHS, Id: R01 HL049277-16

Mesh Terms

  • Amino Acid Substitution
  • Animals
  • Calmodulin
  • Cardiomegaly
  • Mice
  • Mutagenesis, Site-Directed
  • Myocardium
  • Ryanodine Receptor Calcium Release Channel